Skip to main content
Journal of Translational Medicine logoLink to Journal of Translational Medicine
. 2024 Oct 28;22:977. doi: 10.1186/s12967-024-05795-3

Retraction Note: TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway

Linan Zhu 1, Xudong Zhang 1, Xiaorui Fu 1, Zhaoming Li 1, Zhenchang Sun 1, Jingjing Wu 1, Xinhua Wang 1, Feng Wang 1, Xiangke Li 1, Songtao Niu 1, Mengjie Ding 1, Zhenzhen Yang 1, Wanqiu Yang 1, Meifeng Yin 1, Lei Zhang 1, Mingzhi Zhang 1,
PMCID: PMC11520825  PMID: 39468634

Retraction Note: Journal of Translational Medicine (2018) 167:7

10.1186/s12967-018-1383-0

The Editor-in-Chief has retracted the article [1] on the basis that several panels from Fig. 2e and f appear in Fig. 3d, e and f of a previously published article [1] by different authors. The data reported in this article are therefore unreliable.

The Authors did not respond to correspondence from the Publisher about this retraction.

References

[1]. Zhan Y., Liu Y., Wang C., Lin J., Chen M., Chen X., Zhuang C., Liu L., Xu W., Zhou Q., Sun X., Zhang Q., Zhao G., et al Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Oncotarget. 2016; 7: 16038–16048. Retrieved from https://www.oncotarget.com/article/6946/text/.

Footnotes

The online version of the original article can be found at 10.1186/s12967-018-1383-0.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Zhu et al. TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway 2018;16:7 10.1186/s12967-018-1383-0 [DOI] [PMC free article] [PubMed] [Retracted]

Articles from Journal of Translational Medicine are provided here courtesy of BMC

RESOURCES